世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2014年
25期
24-25
,共2页
鲍曼不动杆菌%耐药%碳青霉烯酶
鮑曼不動桿菌%耐藥%碳青黴烯酶
포만불동간균%내약%탄청매희매
acinetobacter baumannii%resistance%carbapenemase
目的：探讨研究鲍曼不动杆菌对临床常用抗菌药物的耐药性及其产碳青霉烯酶情况。方法对我院采集提供的临床标本进行分离筛选鲍曼不动杆菌，采用MicroScanWalkAway-40全自动微生物分析仪鉴定，并对常见10中抗菌药物进行耐药性分析和产碳青霉烯酶菌株的检测。结果共筛选出120株鲍曼不动杆菌，其对头孢哌酮的耐药率最低(19.2%)，对阿莫西林的敏感性最高（43.3%）；对头孢哌酮的耐药率最低（25.8%），对氨苄西林耐药率最高（89.2%），共检测出能够产生碳青霉烯酶的菌株30株，检出率为71.4%。结论鲍曼不动杆菌具有较强的耐药性，其耐药机制与产生碳青霉烯酶有关。
目的：探討研究鮑曼不動桿菌對臨床常用抗菌藥物的耐藥性及其產碳青黴烯酶情況。方法對我院採集提供的臨床標本進行分離篩選鮑曼不動桿菌，採用MicroScanWalkAway-40全自動微生物分析儀鑒定，併對常見10中抗菌藥物進行耐藥性分析和產碳青黴烯酶菌株的檢測。結果共篩選齣120株鮑曼不動桿菌，其對頭孢哌酮的耐藥率最低(19.2%)，對阿莫西林的敏感性最高（43.3%）；對頭孢哌酮的耐藥率最低（25.8%），對氨芐西林耐藥率最高（89.2%），共檢測齣能夠產生碳青黴烯酶的菌株30株，檢齣率為71.4%。結論鮑曼不動桿菌具有較彊的耐藥性，其耐藥機製與產生碳青黴烯酶有關。
목적：탐토연구포만불동간균대림상상용항균약물적내약성급기산탄청매희매정황。방법대아원채집제공적림상표본진행분리사선포만불동간균，채용MicroScanWalkAway-40전자동미생물분석의감정，병대상견10중항균약물진행내약성분석화산탄청매희매균주적검측。결과공사선출120주포만불동간균，기대두포고동적내약솔최저(19.2%)，대아막서림적민감성최고（43.3%）；대두포고동적내약솔최저（25.8%），대안변서림내약솔최고（89.2%），공검측출능구산생탄청매희매적균주30주，검출솔위71.4%。결론포만불동간균구유교강적내약성，기내약궤제여산생탄청매희매유관。
Objective To investigate Acinetobacter baumannii resistance to clinical antimicrobial agents commonly used and carbapenemase producing situations.Methods The clinical specimens collected and provided by our hospital were carried out acinetobacter baumannii isolation and screening by MicroScanWalkAway-40 automatic analyzer identiifcation of microorganisms. And 10 common antimicrobial drugs resistances were analyzed and the productions of carbapenemase strains were detected.Results A total of 120 acinetobacter baumannii were screened, to which cefoperazone resistance rate was lowest (19.2%), the highest sensitivity to amoxicillin (43.3%), lowest rates of resistance to cefoperazone (25.8%) and the highest rate of resistance to ampicillin (89.2%). 30 bacterial strains producing carbapenemase were detected, the detection rate of 71.4%. Conclusion Acinetobacter baumannii has strong resistance and the resistance mechanism is related with carbapenemase production.
